Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
In the human adaptation and optimization of a mouse anti–human respiratory syncytial virus neutralizing antibody, affinity assessment was crucial to distinguish among potential candidates and to evaluate whether this correlated with function in vitro and in vivo. This affinity assessment was complicated by the trimeric nature of the antigen target, respiatory syncytial virus F glycoprotein. In addition, the respiratory syncytial virus fusion (F) glycoprotein is the current leading target for the majority of vaccines and immunotherapies under development.